Babson life sciences entrepreneurial product development immersion for new technologies and solutions (babson l-sprint) program

Active Cooperative Agreement Awarded Last action

Award ID
UE5DA056894
Recipient
Awarding agency
Obligated
$4,447,432

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date 86% complete
Funding
  • $4,150,759.00 Federal
  • $296,673.00 Non-federal
Place of performance
Wellesley Hills, Wellesley, MA 02481, USA

Award details come from USAspending.gov.

Description

Abstract
Babson life sciences entrepreneurial product development immersion for new technologies and solutions (babson l-sprint) program commercialized innovations and new ventures that address certain conditions, including ventures that address the causes, consequences, and treatment of substance use disorders (suds) to improve individual and public health, are still underrepresented amongst recent startups. Commercialization and technology-based start-UPS can be challenging in an academic environment due to varying reward structures, organizational structures and organizational cultures. Many promising scientists are reluctant to pursue intellectual property (IP) protection and investigate commercialization opportunities, even for unique research findings, due to a lack of understanding of the mechanics towards productizing and commercialization. To address these misperceptions and challenges while amplifying the potential impact that academic scientists can make to address suds, the babson life sciences entrepreneurial product development immersion for new technologies and solutions (babson l-sprint) program will reach scientists interested in product development and commercialization as well as to train participants in entrepreneurial thinking that can also increase decision making, improve their organizations and labs from within, especially since product development in the biomedical industry is highly uncertain. The babson l-sprint program includes two aims: aim 1: curriculum development – the babson l-sprint program will develop a specialized curriculum highlighting babson's signature entrepreneurial thought & action ® offering coupled with customized healthcare and biomedical entrepreneurship content on addressing market segmentation and uncertainty, commercializing emerging technologies, scaling for growth, and biomedical community experiences. The program will use live cases, panels, and other experiential learning techniques. Aim 2: courses for skills development – we will also develop a recruitment and outreach strategy using an innovative omnichannel approach including direct marketing utilizing email, relevant conferences, and via NIH nida newsletters and other media as available.

Transactions

Action Federal Non-federal Date
Amendment $302,741 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $312,731 $0
Amendment $312,731 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $313,541 $0
Amendment $313,541 $0
Amendment $313,541 $0
Amendment $107,895 $0
Amendment $107,895 $0
Amendment $107,895 $0
Amendment $107,895 $0
Amendment $316,241 $0
Amendment $316,241 $0
Amendment $316,241 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $11,611 $0
Amendment $11,611 $11,611
Amendment $11,611 $0
Amendment $11,611 $0
Amendment $285,062 $0
Amendment $285,062 $285,062
Original award $285,062 $0
Show all 37

Quick answers

Who received award UE5DA056894?

UE5DA056894 was awarded to Babson College by National Institute on Drug Abuse (National Institutes of Health) on August 15, 2022.

How much is award UE5DA056894 worth?

$4,447,432 has been obligated on UE5DA056894: $4,150,759 in federal funding and $296,673 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award